BALY vs JNJ · rev $1.55B vs P/E 17, rev $49.37B
Bally's Corp (BALY) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Bally's Corp (BALY) is a resorts & casinos company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported BALY revenue for 2026-06-30 was $1.55B. Net income was -$308.0M. BALY currently screens at market cap $661.8M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
BALY currently screens at market cap $661.8M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the BALY and JNJ stock pages for the full models.
Not investment advice.